About Us

Spiderwort is a biotechnology company with a transformative platform of cellulose-based biomaterials that will serve as the scaffolds for everything from regenerative medicine to lab-grown meat. Spiderwort’s biomaterials have shown promise in the treatment of spinal cord Injuries and soft tissue regeneration.


Led by Dr. Charles M. Cuerrier, CEO, and inspired by the work of TED Fellow, Dr. Andrew E. Pelling, CSO, Spiderwort is driven to push the limits of science every day to create innovative, natural solutions to some of life’s biggest problems.

Spiderwort was born from curiosity-driven exploration with the potential to transform a variety of industries.


Charles M. Cuerrier, PhD

Chief Executive Officer | Co-founder

Andrew E. Pelling, CSO

Andrew E. Pelling, PhD, FRSB

Chief Scientific Officer | Co-founder

Stephen Hanson, PhD, MBA

Business Development Director

Scott Jarvis

Scott Jarvis, CPA

Chief Financial Officer

Board of Directors

Dane Bedward

Board Chairman

Charles M. Cuerrier

Board member

Patrick Zhang

Patrick Zhang

Board member

Supported By

Ontario Bioscience Innovation Organization
Creative Destruction Lab - Vancouver
Ontario Centres of Excellence (OCE)
National Research Council of Canada
BioTalent Canada
Natural Sciences and Engineering Research Council of Canada
The Pelling Lab
Collège La Cité
Startup Garage
Telfer School of Management

Want to help
make a difference?

Hear More From Us